rivastigmine 4.5 MG Oral Capsule
1 INDICATIONS AND USAGE Rivastigmine tartrate capsule is an acetylcholinesterase inhibitor indicated for treatment of: Mild-to-moderate dementia of the Alzheimer’s type (AD) (1.1) Mild-to-moderate dementia associated with Parkinson’s disease (PD) (1.2) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PD).
dr. reddy's laboratories limited
Related Pills
rivastigmine 3 MG Oral Capsule
dr. reddy's laboratories limited
rivastigmine 1.5 MG Oral Capsule
dr. reddy's laboratories limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
RIVASTIGMINE TARTRATE capsules USP, equivalent to 1.5 mg, 3 mg, 4.5 mg or 6 mg of rivastigmine base are available as follows:
RIVASTIGMINE TARTRATE capsules USP, 1.5 mg are white to off-white powder filled in size ‘2’ hard gelatin capsules with light tan opaque color cap and light tan opaque color body, imprinted ‘RDY” on cap and ‘352’ on body with black ink and are supplied in bottles of 30, 60, 100 and 500. Bottles of 30 NDC 55111-352-30 Bottles of 60 NDC 55111-352-60 Bottles of 100 NDC 55111-352-01 Bottles of 500 NDC 55111-352-05
RIVASTIGMINE TARTRATE capsules USP, 3 mg are white to off-white powder filled in size ‘2’ hard gelatin capsules with brown opaque color cap and brown opaque color body, imprinted ‘RDY’ on cap and ‘353’ on body with black ink and are supplied in bottles of 30, 60, 100 and 500. Bottles of 30 NDC 55111-353-30 Bottles of 60 NDC 55111-353-60 Bottles of 100 NDC 55111-353-01 Bottles of 500 NDC 55111-353-05
RIVASTIGMINE TARTRATE capsules USP, 4.5 mg are white to off-white powder filled in size ‘2’ hard gelatin capsules with swedish orange opaque color cap and swedish orange opaque color body, imprinted 'RDY' on cap and '354' on body with black ink and are supplied in bottles of 30, 60, 100 and 500. Bottles of 30 NDC 55111-354-30 Bottles of 60 NDC 55111-354-60 Bottles of 100 NDC 55111-354-01 Bottles of 500 NDC 55111-354-05
RIVASTIGMINE TARTRATE capsules USP, 6 mg are white to off-white powder filled in size ‘2’ hard gelatin capsules with swedish orange opaque color cap and brown opaque color body, imprinted ‘RDY’ on cap and ‘355’ on body with black ink and are supplied in bottles of 30, 60, 100 and 500. Bottles of 30 NDC 55111-355-30 Bottles of 60 NDC 55111-355-60 Bottles of 100 NDC 55111-355-01 Bottles of 500 NDC 55111-355-05 Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
More pills like CAPSULE RDY 354